149096-35-5 Usage
Uses
Used in Pharmaceutical and Agrochemical Industries:
1H-Imidazole-4-carboxylic acid, 1-propyl-(9CI) serves as a crucial building block in the synthesis of various pharmaceuticals and agrochemicals. Its unique structure allows for the creation of new compounds with potential therapeutic or pesticidal properties, contributing to the development of innovative treatments and products in these industries.
Used in Medicinal Chemistry Research:
As a compound with potential biological activities, 1H-Imidazole-4-carboxylic acid, 1-propyl-(9CI) is utilized in medicinal chemistry research to explore its interactions with biological targets. This research aims to uncover its potential as a therapeutic agent or a lead compound for the development of new drugs.
Used in Drug Discovery:
1H-Imidazole-4-carboxylicacid,1-propyl-(9CI)'s presence in drug discovery processes is significant, as it may possess properties that can be harnessed to create novel medications. Researchers investigate its pharmacological profile, including its binding affinity, selectivity, and potential side effects, to assess its suitability as a drug candidate.
Check Digit Verification of cas no
The CAS Registry Mumber 149096-35-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,9,0,9 and 6 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 149096-35:
(8*1)+(7*4)+(6*9)+(5*0)+(4*9)+(3*6)+(2*3)+(1*5)=155
155 % 10 = 5
So 149096-35-5 is a valid CAS Registry Number.
149096-35-5Relevant articles and documents
3-AZABICYCLO(3.1.0)HEXANE DERIVATIVES HAVING KDM5 INHIBITORY ACTIVITY AND USE THEREOF
-
Paragraph 0384, (2021/11/13)
The present invention provides KDM5 inhibitor. The compound disclosed herein represented by the general formula (I) : wherein all symbols have the same meanings as the definitions described in the specification; or a salt thereof is useful as a prophylact
INHIBITORS OF AKT ACTIVITY
-
Page/Page column 140, (2010/11/25)
The instant invention provides for substituted naphthyridine compounds that inhibit Akt activity. In particular, the compounds disclosed selectively inhibit one or two of the Akt isoforms. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting Akt activity by administering the compound to a patient in need of treatment of cancer.
ALKYLATION OF METHYL IMIDAZOLE-4(5)-CARBOXYLATE WITH 1-BROMOPROPANE AND ETHYL BENZENESULFONATE
Mishin, M.A.,Poznyakova, L.N.,Piotrovskii, L.B.,Erusalimskii, G.B.
, p. 2126 - 2129 (2007/10/02)
Methyl 1-propylimidazole-4- and 1-propylimidazole-5-carboxylates were obtained in the ratio of ca.2:1 by alkylation of methyl imidazole-4(5)-carboxylate with 1-bromopropane in an alkaline medium.Reaction of methyl imidazole-4(5)-carboxylate with ethyl benzenesulfonate gave a 1:1 mixture of methyl 1-ethylimidazole-4- and 1-ethylimidazole-5-carboxylates.The regioselectivity of the alkylation may be due to the fact that the reaction is entropy-controlled.